BLISS GVS PHARMA
Back to Balance Sheet
|
BLISS GVS PHARMA Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹438 Cr | ₹404 Cr | ₹385 Cr | ₹393 Cr | ₹464 Cr |
What is the latest Sundry Debtors ratio of BLISS GVS PHARMA ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹438 Cr |
| Mar2024 | ₹404 Cr |
| Mar2023 | ₹385 Cr |
| Mar2022 | ₹393 Cr |
| Mar2021 | ₹464 Cr |
How is Sundry Debtors of BLISS GVS PHARMA Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹438 Cr | 8.41 | |
| Mar2024 | ₹404 Cr | 4.98 | |
| Mar2023 | ₹385 Cr | -1.93 | |
| Mar2022 | ₹393 Cr | -15.32 | |
| Mar2021 | ₹464 Cr | - | |
Compare Sundry Debtors of peers of BLISS GVS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BLISS GVS PHARMA | ₹1,808.0 Cr | 9.8% | 12.6% | 1.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,068.0 Cr | -0.2% | 7.1% | 1.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,847.0 Cr | 0.8% | -6% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹127,985.0 Cr | 1.2% | 6.4% | 13.1% | Stock Analytics | |
| CIPLA | ₹122,826.0 Cr | -0.2% | 1.4% | -0.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,418.0 Cr | 1.2% | 5.8% | 4.2% | Stock Analytics | |
BLISS GVS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BLISS GVS PHARMA | 9.8% |
12.6% |
1.9% |
| SENSEX | 0% |
2.7% |
6.8% |
You may also like the below Video Courses